Program

Goals and Objectives

The goal of this program is to provide a training environment for future scientists in Canada who can undertake high-quality post-market research in the area of drug safety and effectiveness and training that is focused on integrative thinking within an interdisciplinary environment.

The main program objectives are to:

  • Provide trainees with an opportunity to learn and apply a broad range of concepts related to drug safety and effectiveness research;
  • Provide an opportunity to develop depth in specific knowledge and advanced skills based on the individualized needs of the trainee;
  • Improve the mentoring and training environment for post-marketed drug safety and effectiveness health researchers in Canada;
  • Foster collaborative research across drug safety and effectiveness research teams, scientific disciplines and with clinician and policy maker knowledge users;
  • Provide training on the ethical conduct of research and related ethical issues, knowledge translation (KT), and professional skills, such as communication, teamwork, project management and leadership; and,
  • Develop a network of mentors, trainees and knowledge users across Canada linked with DSEN focused on capacity building for DS&E research.

 

Trainee Objectives

Trainees of this program focus on knowledge acquisition and skill-building within a training environment that spans multiple scientific research areas. Specific trainee objectives include:

  1. Completing the program curriculum, including attendance at the DSECT Annual Symposium, the interactive, web-based sessions, and self-study modules;
  2. Producing a learning plan, grant proposal (mock assignment), narrative commentaries, and progress reports;
  3. Presenting primary work at the DSECT Annual Symposium and during online webinars;
  4. Completing the research Objective Structured Knowledge Translation Experience (OSKTE);
  5. Gaining exposure to other scientific disciplines through completing self-study modules, mentorship, and/or a practicum; and,
  6. Exchanging ideas and networking with faculty, trainees and key knowledge users or stakeholders working in drug safety and effectiveness research.